Langerhans cell histiocytosis successfully treated with combination of thalidomide and corticosteroid
There is no gold standard of treatment for Langerhans cell histiocytosis (LCH) in adults.Around 50% of patients with LCH were unresponsive to the standard therapy and no standard regimen was recommended for patients with refractory LCH.A combination of thalidomide and corticosteroid may be a therapeutic option in patients with LCH.
Authors
- Candra Kurniawan (ORCID: https://orcid.org/0000-0002-3421-2269)
- Nadia Ayu Mulansari (ORCID: https://orcid.org/0000-0002-2242-7641)
- Abdul Muthalib
Institutions
- University of Indonesia (ID)
Publication Details
- Journal
- European Journal of Case Reports in Internal Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.12890/2025_005534
- Primary Topic
- Histiocytic Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00